Cardiol Therapeutics Inc. (TSX:CRDL)
Canada
· Delayed Price · Currency is CAD 1.860
-0.050 (-2.62%)
Apr 28, 2026, 4:00 PM EST
Cardiol Therapeutics Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
18
Market Cap
208.08M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Auxly Cannabis Group | 151.48M |
| Cannara Biotech | 113.01M |
| BioSyent | 43.05M |
| Aurora Cannabis | 373.12M |
| Organigram Global | 279.99M |
| TerrAscend | 357.26M |
| Charlotte's Web Holdings | 68.41M |
| Ascend Wellness Holdings | 686.36M |
Cardiol Therapeutics News
- 23 hours ago - Cardiol Therapeutics Expands U.S. MAVERIC Phase III Trial Network to Address Growing Interest in the Pivotal Program - PRNewsWire
- 14 days ago - Cardiol Therapeutics to Highlight MAVERIC Phase III Trial and Recently Published ARCHER Results in Live Interview with Barchart - Newsfile Corp
- 22 days ago - Cardiol Therapeutics (CRDL) Receives 'Buy' Rating from Canaccord Genuity | CRDL Stock News - GuruFocus
- 27 days ago - Cardiol Therapeutics Announces Year-End 2025 Update on Operations - Newsfile Corp
- 7 weeks ago - Cardiol Therapeutics Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
- 2 months ago - Cardiol Therapeutics to Present at TD Cowen 46th Annual Health Care Conference - Newsfile Corp
- 2 months ago - Cardiol Therapeutics' ARCHER Phase II Study Results Published in ESC Heart Failure - Newsfile Corp
- 3 months ago - Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million - Newsfile Corp